4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-030406
CEO and CFO bought 2,000 shares at $8.79 ($17,580)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-11-02 | Purchase | +2,000 | $8.79 | $17,580 | 2,721,886 | D |
| Open-market purchases · 2,000 sh · avg $8.79 · $17,580 | |||||||
Loading xslF345X03/ownership.xml…